Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $800.00 | 1 | 66.5% |
| Food and Beverage | $388.41 | 4 | 32.3% |
| Education | $15.27 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Almirall LLC | $800.00 | 1 | $0 (2024) |
| Allergan, Inc. | $125.69 | 1 | $0 (2020) |
| Verrica Pharmaceuticals Inc. | $124.98 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $122.04 | 1 | $0 (2017) |
| Lupin Pharmaceuticals, Inc | $15.70 | 1 | $0 (2017) |
| PFIZER INC. | $15.27 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $924.98 | 2 | Almirall LLC ($800.00) |
| 2023 | $15.27 | 1 | PFIZER INC. ($15.27) |
| 2020 | $125.69 | 1 | Allergan, Inc. ($125.69) |
| 2017 | $137.74 | 2 | Regeneron Healthcare Solutions, Inc. ($122.04) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: DERMATOLOGY | ||||||
| 09/20/2024 | Almirall LLC | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 04/12/2023 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 03/04/2020 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $125.69 | General |
| 11/09/2017 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $122.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2017 | Lupin Pharmaceuticals, Inc | Suprax (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Antibiotic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 329 | 623 | $114,437 | $29,579 |
| 2022 | 11 | 405 | 742 | $165,471 | $35,023 |
| 2021 | 13 | 456 | 837 | $200,581 | $38,025 |
| 2020 | 14 | 427 | 644 | $156,046 | $25,283 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 109 | $28,488 | $9,289 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 88 | $11,746 | $5,077 | 43.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 31 | $13,640 | $3,999 | 29.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 33 | $12,252 | $3,620 | 29.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 51 | 63 | $18,228 | $3,078 | 16.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 28 | 34 | $6,968 | $2,191 | 31.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 17 | 17 | $6,115 | $1,285 | 21.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 23 | 28 | $12,838 | $617.03 | 4.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 35 | 220 | $4,162 | $423.49 | 10.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 114 | $36,880 | $8,660 | 23.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 71 | $28,502 | $8,594 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 100 | $15,568 | $5,168 | 33.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 29 | $10,672 | $2,717 | 25.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 48 | 63 | $18,994 | $2,569 | 13.5% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 19 | 19 | $6,821 | $1,715 | 25.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 26 | 26 | $4,263 | $1,618 | 38.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $11,494 | $1,557 | 13.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 11 | 14 | $7,000 | $1,169 | 16.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 36 | 42 | $19,404 | $789.60 | 4.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 40 | 247 | $5,873 | $466.15 | 7.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 97 | 147 | $50,664 | $12,088 | 23.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 39 | 59 | $32,454 | $7,054 | 21.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 29 | 44 | $16,192 | $4,200 | 25.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 51 | 66 | $11,118 | $3,458 | 31.1% |
| 17000 | Destruction of skin growth | Office | 2021 | 57 | 73 | $20,586 | $3,094 | 15.0% |
About Dr. Jennifer Chen, MD
Dr. Jennifer Chen, MD is a Dermatology healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2009. The National Provider Identifier (NPI) number assigned to this provider is 1184851297.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Chen, MD has received a total of $1,204 in payments from pharmaceutical and medical device companies, with $924.98 received in 2024. These payments were reported across 6 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($800.00).
As a Medicare-enrolled provider, Chen has provided services to 1,617 Medicare beneficiaries, totaling 2,846 services with total Medicare billing of $127,909. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Stanford, CA
- Active Since 06/16/2009
- Last Updated 04/16/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1184851297
Products in Payments
- YCANTH (Drug) $124.98
- DUPIXENT DUPILUMAB INJECTION (Biological) $122.04
- Suprax (Drug) $15.70
- CIBINQO (Drug) $15.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Stanford
Matthew Lewis, Md, MD
Dermatology — Payments: $303,775
Justin Ko, Md, MD
Dermatology — Payments: $243,220
David Fiorentino, Md, MD
Dermatology — Payments: $218,980
Zakia Rahman, Md, MD
Dermatology — Payments: $171,847
Anne Lynn Chang, Md, MD
Dermatology — Payments: $148,354
Youn-Hee Kim, Md, MD
Dermatology — Payments: $87,849